Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-02

FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Original Application (Nexus Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Nexus Pharmaceuticals LLC's original-application submission for isoproterenol hydrochloride, making this generic beta-adrenergic agonist available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoproterenol hydrochloride (Isoproterenol hydrochloride)

Snippet

ORIG AP for ISOPROTERENOL HYDROCHLORIDE (ISOPROTERENOL HYDROCHLORIDE)